Target intelligence / Profile preview

Hydrogen Nuclei

Molecular classification
Other
01

Overview

The term **"hydrogen nuclei"** refers to the atomic nucleus of hydrogen, which consists of a single proton in its most common isotope (^1H), or may include one or two neutrons in the isotopes deuterium (^2H) and tritium (^3H). In chemistry and biology, hydrogen atoms are essential components of water and organic molecules. In nuclear physics, "hydrogen nuclei" are important for processes such as nuclear fusion—where they combine under extreme conditions to form helium and release energy, as occurs in stars like the Sun[8]. However, "hydrogen nuclei" do not refer to any receptor, enzyme, transporter protein, or other conventional biological macromolecule that would be considered a therapeutic target. They do not have structure–function relationships typical for drug targets nor do they participate directly in signal transduction or disease pathways. Thus, listing "hydrogen nuclei" as a molecular/receptor target is incorrect within biomedical research conventions. **Note:** If you intended “Hydrogenase” (an enzyme that catalyzes reactions involving molecular hydrogen), see [1] for details on its classes ([Fe]-Hydrogenase etc.), but “Hydrogen nuclei” itself is not an actionable biological/therapeutic target.

Other names
Proton (in nuclear physics)Hydrogen nucleus^1H (protium nucleus)Deuteron (^2H, deuterium nucleus)Triton (^3H, tritium nucleus)
02

Mechanism of action

Not applicable

03

Biological functions

Not applicable as a biological macromolecule or therapeutic targetFundamental component of atoms and molecules in all living matter[6]
04

Disease associations

Not applicable
05

Safety considerations

None relevant to drug targeting; hydrogen gas is flammable but this is unrelated to the "hydrogen nuclei" as a molecular target[6]
06

Interacting drugs

None (hydrogen nuclei themselves are not drug targets)
07

Biomarkers

None specific to hydrogen nuclei as a therapeutic target

Beyond the preview

Go deeper on Hydrogen Nuclei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrogen Nuclei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call